Deutsche Bank’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-534
| Closed | -$3K | – | 4378 |
|
|
2020
Q4 | $3K | Buy |
+534
| New | +$3K | ﹤0.01% | 4235 |
|
|
2020
Q1 | – | Sell |
-92
| Closed | – | – | 4086 |
|
|
2019
Q4 | $0 | Sell |
92
-770
| -89% | – | ﹤0.01% | 4671 |
|
|
2019
Q3 | $1K | Sell |
862
-19,564
| -96% | -$22.7K | ﹤0.01% | 4498 |
|
|
2019
Q2 | $81K | Sell |
20,426
-277,475
| -93% | -$1.1M | ﹤0.01% | 4154 |
|
|
2019
Q1 | $1.28M | Buy |
297,901
+180,201
| +153% | +$774K | ﹤0.01% | 2812 |
|
|
2018
Q4 | $676K | Buy |
117,700
+108,142
| +1,131% | +$621K | ﹤0.01% | 3103 |
|
|
2018
Q3 | $130K | Sell |
9,558
-122,135
| -93% | -$1.66M | ﹤0.01% | 4260 |
|
|
2018
Q2 | $1.56M | Sell |
131,693
-204,193
| -61% | -$2.42M | ﹤0.01% | 3100 |
|
|
2018
Q1 | $3.77M | Buy |
335,886
+160,940
| +92% | +$1.81M | ﹤0.01% | 2426 |
|
|
2017
Q4 | $1.17M | Sell |
174,946
-116,088
| -40% | -$775K | ﹤0.01% | 3047 |
|
|
2017
Q3 | $2.38M | Buy |
291,034
+38,809
| +15% | +$318K | ﹤0.01% | 2397 |
|
|
2017
Q2 | $1.13M | Buy |
252,225
+138,519
| +122% | +$622K | ﹤0.01% | 2903 |
|
|
2017
Q1 | $625K | Buy |
+113,706
| New | +$625K | ﹤0.01% | 2891 |
|
|
2016
Q4 | – | Sell |
-23,349
| Closed | -$164K | – | 4405 |
|
|
2016
Q3 | $164K | Buy |
+23,349
| New | +$164K | ﹤0.01% | 3584 |
|
|
2016
Q1 | – | Sell |
-500
| Closed | -$6K | – | 4711 |
|
|
2015
Q4 | $6K | Buy |
+500
| New | +$6K | ﹤0.01% | 4550 |
|